NCT00003041View on ClinicalTrials.gov

Pyrazoloacridine in Treating Women With Refractory Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 1997

Study Completion Date

January 31, 2002

Conditions
Breast Cancer
Interventions
DRUG

pyrazoloacridine

Trial Locations (5)

29605

Cancer Centers of the Carolinas, Greenville

40503

Central Baptist Hospital, Lexington

43210

Arthur G. James Cancer Hospital - Ohio State University, Columbus

43214

Grant/Riverside Methodist Hospitals, Columbus

43222

Mount Carmel, Columbus

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Ohio State University Comprehensive Cancer Center

OTHER

NCT00003041 - Pyrazoloacridine in Treating Women With Refractory Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter